Funder
National Institute on Drug Abuse
Patient-Centered Outcomes Research Institute
Indivior, Inc
Alkermes, Inc
Braeburn Pharm, Inc.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Immunology,Immunology and Allergy,Neuroscience (miscellaneous)
Reference26 articles.
1. Burke J, Orenstein R (1997) The Axemaker’s Gift. Tarcher/Putnam, New York
2. Chalk M, Baser O, Halpern R, Gastfriend DR (2011) Healthcare cost outcomes for alcohol dependence: A comparison of four treatments. Presented at American Society of Addiction Medicine 42nd Annual Medical-Scientific Conference, Washington, DC
3. Colquhoun R, DY T, Hull S (2005) A comparison of oral and implant naltrexone outcomes at 12 months. J Opioid Manag 1(5):249–256
4. Comer SD, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW (2002) Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology (Berl) 159(4):351–360. Epub 2001 Nov 1
5. Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, O’Brien CP (2006) Injectable, sustained-release naltrexone for the treatment of opioid dependence. Arch Gen Psychiatry 63:210–218
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献